博瑞医药：2022年度净利润约2.57亿元，同比增加5.25%

七印授权

493KCSS6HN0Z83ZGJCEHMPXPPPQ8H7PYNPLY3S27DDIITIKUH8

2023-02-27 09:03:30

article

2766C64AEAAA2CB297C8B64FC4546D744F541486A93009AD2A0207D7A2E53B67

zh-CN

AC928D6BAB445D5EEC81A1B2B71F1BB3E34E4123

14157608

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

bfef92f6e5d49339d6aeaafbb51abbf6238901a5ac22150444509e561e4fc6536fb9bbc445a3392e71d0bdbab06637bc9f4d1ffb5dcae99290666e8888dee4b21b

{"parameters":{"adaptation":"n","price":"100000"},"type":"cm"}

yuanben_63fc71e20c78e7.58808389

原本认证

https://www.yuanben.io/article/d7e82330-92e6-43d2-9958-b8f235d6a4e3

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}